We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| UnitedHealth Group Inc | NYSE:UNH | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -4.52 | -0.87% | 516.83 | 520.225 | 515.23 | 519.20 | 3,055,557 | 01:00:00 |
From May 2023 to May 2024
By Anthony O. Goriainoff
The U.K.'s Competition and Markets authority said it hasn't found any competition concerns in the UnitedHealth Group and EMIS Group merger so far following an in-depth investigation, clearing the 1.2 billion pounds ($1.52 billion) deal provisionally.
The regulator said Friday that it will now consult on its findings and listen to any further views before it reaches a final decision, adding that it welcomed responses from interested parties until Sept. 1. Its final report is due Oct. 5, it said.
UnitedHealth and EMIS are specialist health care tech and software companies, which provide services to the U.K.'s National Health Service.
In March the CMA said it decided to refer the merger to a next phase investigation after considering that initial undertakings wouldn't achieve a reasonable solution following concerns that it could reduce competition, leading to worse outcomes for the National Health Service and patients and taxpayers.
Write to Anthony O. Goriainoff at anthony.orunagoriainoff@dowjones.com
(END) Dow Jones Newswires
August 11, 2023 02:37 ET (06:37 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year UnitedHealth Chart |
1 Month UnitedHealth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
